- directed: true
  graph:
    disease: Bacterial pneumonia
    disease_mesh: MESH:D018410
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1392
    - key: causes
      source: NCBITaxon:1392
      target: MESH:D018410
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1392
      label: OrganismTaxon
      name: Bacillus anthracis
    - id: MESH:D018410
      label: Disease
      name: Bacterial pneumonia
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Bacterial_pneumonia#Types https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
  comments: Different bacterial species can cause pneumonia, the most frequent ones are Streptococcus pneumoniae, Staphylococcus aureus, and Bacillus anthracis, among the gram-positive types of bacteria. Gram-negative examples of bacteria causing pneumonia are Haemophilus influenzae, Klebsiella pneumoniae and Escherichia coli.
- directed: true
  graph:
    disease: Pyelonephritis
    disease_mesh: MESH:D011704
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D011704
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D011704
      label: Disease
      name: Pyelonephritis
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action https://en.wikipedia.org/wiki/Pyelonephritis#Causes https://en.wikipedia.org/wiki/Pyelonephritis#Simple
- directed: true
  graph:
    disease: Anthrax
    disease_mesh: MESH:D000881
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1392
    - key: causes
      source: NCBITaxon:1392
      target: MESH:D000881
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1392
      label: OrganismTaxon
      name: Bacillus anthracis
    - id: MESH:D000881
      label: Disease
      name: Anthrax
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Anthrax#Bacteria https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
- directed: true
  graph:
    disease: Staphylococcal pneumonia
    disease_mesh: MESH:D011023
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D011023
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D011023
      label: Disease
      name: Staphylococcal pneumonia
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Bacterial_pneumonia#Gram-positive https://en.wikipedia.org/wiki/Staphylococcus_aureus#Role_in_disease https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
  comments: Different bacterial species can cause pneumonia, the most frequent ones are Streptococcus pneumoniae, Staphylococcus aureus, and Bacillus anthracis, among the gram-positive types of bacteria. Gram-negative examples of bacteria causing pneumonia are Haemophilus influenzae, Klebsiella pneumoniae and Escherichia coli.
- directed: true
  graph:
    disease: Chlamydial pneumonia
    disease_mesh: MESH:D061387
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:83558
    - key: causes
      source: NCBITaxon:83558
      target: MESH:D061387
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:83558
      label: OrganismTaxon
      name: Chlamydia pneumoniae
    - id: MESH:D061387
      label: Disease
      name: Chlamydial pneumonia
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Chlamydia#Infants https://pubmed.ncbi.nlm.nih.gov/32809709/ https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
  comments: Different bacterial species can cause pneumonia, the most frequent ones are Streptococcus pneumoniae, Staphylococcus aureus, and Bacillus anthracis, among the gram-positive types of bacteria. Gram-negative examples of bacteria causing pneumonia are Haemophilus influenzae, Klebsiella pneumoniae and Escherichia coli.
- directed: true
  graph:
    disease: Pneumonia due to Streptococcus
    disease_mesh: MESH:D011018
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1313
    - key: causes
      source: NCBITaxon:1313
      target: MESH:D011018
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1313
      label: OrganismTaxon
      name: Streptococcus pneumoniae
    - id: MESH:D011018
      label: Disease
      name: Pneumonia due to Streptococcus
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Bacterial_pneumonia#Types https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
  comments: Different bacterial species can cause pneumonia, the most frequent ones are Streptococcus pneumoniae, Staphylococcus aureus, and Bacillus anthracis, among the gram-positive types of bacteria. Gram-negative examples of bacteria causing pneumonia are Haemophilus influenzae, Klebsiella pneumoniae and Escherichia coli.
- directed: true
  graph:
    disease: Streptococcus pyogenes infection
    disease_mesh: MESH:D013290
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1314
    - key: causes
      source: NCBITaxon:1314
      target: MESH:D013290
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1314
      label: OrganismTaxon
      name: Streptococcus pyogenes
    - id: MESH:D013290
      label: Disease
      name: Streptococcus pyogenes infection
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
- directed: true
  graph:
    disease: Infection due to Staphylococcus aureus
    disease_mesh: MESH:D013203
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1280
    - key: causes
      source: NCBITaxon:1280
      target: MESH:D013203
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1280
      label: OrganismTaxon
      name: Staphylococcus aureus
    - id: MESH:D013203
      label: Disease
      name: Infection due to Staphylococcus aureus
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action
- directed: true
  graph:
    disease: Bacterial conjunctivitis
    disease_mesh: MESH:D003234
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:1279
    - key: causes
      source: NCBITaxon:1279
      target: MESH:D003234
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:1279
      label: OrganismTaxon
      name: Staphylococcus sp.
    - id: MESH:D003234
      label: Disease
      name: Bacterial conjunctivitis
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action https://en.wikipedia.org/wiki/Conjunctivitis#Bacterial
- directed: true
  graph:
    disease: Pneumonia due to Mycoplasma pneumoniae
    disease_mesh: MESH:D003234
    drug: levofloxacin
    drug_mesh: MESH:D064704
    drugbank: DB:DB01137
  links:
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR035516
    - key: negatively regulates
      source: MESH:D064704
      target: InterPro:IPR013760
    - key: positively regulates
      source: InterPro:IPR035516
      target: GO:0006260
    - key: positively regulates
      source: InterPro:IPR013760
      target: GO:0006260
    - key: in taxon
      source: GO:0006260
      target: NCBITaxon:2104
    - key: causes
      source: NCBITaxon:2104
      target: MESH:D003234
  multigraph: true
  nodes:
    - id: MESH:D064704
      label: Drug
      name: levofloxacin
    - id: InterPro:IPR035516
      label: GeneFamily
      name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    - id: InterPro:IPR013760
      label: GeneFamily
      name: DNA topoisomerase, type IIA-like domain superfamily
    - id: GO:0006260
      label: BiologicalProcess
      name: Bacterial DNA replication
    - id: NCBITaxon:2104
      label: OrganismTaxon
      name: Mycoplasma pneumoniae
    - id: MESH:D003234
      label: Disease
      name: Pneumonia due to Mycoplasma pneumoniae
  reference: https://go.drugbank.com/drugs/DB01137#mechanism-of-action https://en.wikipedia.org/wiki/Levofloxacin#Mechanism_of_action https://en.wikipedia.org/wiki/Conjunctivitis#Bacterial
  comments: Different bacterial species can cause pneumonia, the most frequent ones are Streptococcus pneumoniae, Staphylococcus aureus, and Bacillus anthracis, among the gram-positive types of bacteria. Gram-negative examples of bacteria causing pneumonia are Haemophilus influenzae, Klebsiella pneumoniae and Escherichia coli.
- directed: true
  graph:
    disease: Streptococcus pyogenes infection
    disease_mesh: MESH:D013290
    drug: quinupristin
    drug_mesh: MESH:C113825
    drugbank: DB:DB01369
  links:
    - key: decreases activity of
      source: MESH:C113825
      target: MESH:D054681
    - key: negatively regulates
      source: MESH:C113825
      target: Pfam:PF00466
    - key: negatively regulates
      source: MESH:C113825
      target: Pfam:PF00237
    - key: positively regulates
      source: Pfam:PF00466
      target: GO:0006412
    - key: positively regulates
      source: Pfam:PF00237
      target: GO:0006412
    - key: location of
      source: MESH:D054681
      target: GO:0000048
    - key: positively correlated with
      source: GO:0000048
      target: GO:0006412
    - key: in taxon
      source: GO:0006412
      target: NCBITaxon:1314
    - key: causes
      source: NCBITaxon:1314
      target: MESH:D013290
  multigraph: true
  nodes:
    - id: MESH:C113825
      label: Drug
      name: quinupristin
    - id: MESH:D054681
      label: ChemicalSubstance
      name: Ribosome Subunits, Large, Bacterial
    - id: GO:0006412
      label: BiologicalProcess
      name: translation
    - id: GO:0000048
      label: MolecularActivity
      name: peptidyltransferase activity
    - id: Pfam:PF00237
      label: GeneFamily
      name: Ribosomal protein L22p/L17e
    - id: Pfam:PF00466
      label: GeneFamily
      name: Ribosomal protein L10
    - id: NCBITaxon:1314
      label: OrganismTaxon
      name: Streptococcus pyogenes
    - id: MESH:D013290
      label: Disease
      name: Streptococcus pyogenes infection
  reference: https://go.drugbank.com/drugs/DB01369#mechanism-of-action https://en.wikipedia.org/wiki/Quinupristin https://www.tandfonline.com/doi/abs/10.1517/13543784.7.4.591 https://en.wikipedia.org/wiki/Quinupristin/dalfopristin#Mechanism_of_action
  comments: This drug is used in combination with dalfopristin. Both interfere with the bacterial protein synthesis, at different stages of the translation. Quinupristin inhibits the late phase of protein synthesis, whereas dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome. In combination, both drugs are more effective than each used individually (https://go.drugbank.com/drugs/DB01369#description).
- directed: true
  graph:
    disease: Osteoarthritis
    disease_mesh: MESH:D010003
    drug: Nabumetone
    drug_mesh: MESH:D007660
    drugbank: DB:DB00461
  links:
    - key: produces
      source: MESH:D007660
      target: CHEBI:35628
    - key: decreases activity of
      source: CHEBI:35628
      target: UniProt:P23219
    - key: decreases activity of
      source: CHEBI:35628
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0002829
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D010003
    - key: positively correlated with
      source: HP:0002829
      target: MESH:D010003
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: Nabumetone
    - id: CHEBI:35628
      label: Drug
      name: (6-methoxy-2-naphthyl)acetic acid
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0002829
      label: PhenotypicFeature
      name: Joint pain
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D010003
      label: Disease
      name: Osteoarthritis
  reference: https://go.drugbank.com/drugs/DB00461#mechanism-of-action https://en.wikipedia.org/wiki/Nabumetone
  comments: Nabumetone is a prodrug, which is metabolised into the pharmacologically active drug (CHEBI:35628, 6-methoxy-2-naphthyl acetic acid). Note that the drug preferentially blocks COX-2 activity.
- directed: true
  graph:
    disease: Rheumatoid arthritis
    disease_mesh: MESH:D001172
    drug: Nabumetone
    drug_mesh: MESH:D007660
    drugbank: DB:DB00461
  links:
    - key: produces
      source: MESH:D007660
      target: CHEBI:35628
    - key: decreases activity of
      source: CHEBI:35628
      target: UniProt:P23219
    - key: decreases activity of
      source: CHEBI:35628
      target: UniProt:P35354
    - key: participates in
      source: UniProt:P23219
      target: REACT:R-HSA-2162123
    - key: participates in
      source: UniProt:P35354
      target: REACT:R-HSA-2162123
    - key: increases abundance of
      source: REACT:R-HSA-2162123
      target: MESH:D011453
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0002829
    - key: positively correlated with
      source: MESH:D011453
      target: HP:0001386
    - key: positively correlated with
      source: HP:0001386
      target: MESH:D001172
    - key: positively correlated with
      source: HP:0002829
      target: MESH:D001172
  multigraph: true
  nodes:
    - id: MESH:D007660
      label: Drug
      name: Nabumetone
    - id: CHEBI:35628
      label: Drug
      name: (6-methoxy-2-naphthyl)acetic acid
    - id: UniProt:P23219
      label: Protein
      name: Prostaglandin G/H synthase 1
    - id: UniProt:P35354
      label: Protein
      name: Prostaglandin G/H synthase 2
    - id: REACT:R-HSA-2162123
      label: BiologicalProcess
      name: Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
    - id: MESH:D011453
      label: ChemicalSubstance
      name: Prostaglandins
    - id: HP:0002829
      label: PhenotypicFeature
      name: Joint pain
    - id: HP:0001386
      label: PhenotypicFeature
      name: Joint swelling
    - id: MESH:D001172
      label: Disease
      name: Rheumatoid arthritis
  reference: https://go.drugbank.com/drugs/DB00461#mechanism-of-action https://en.wikipedia.org/wiki/Nabumetone
  comments: Nabumetone is a prodrug, which is metabolised into the pharmacologically active drug (CHEBI:35628, 6-methoxy-2-naphthyl acetic acid). Note that the drug preferentially blocks COX-2 activity.
- directed: true
  graph:
    disease: Angina pectoris
    disease_mesh: MESH:D000787
    drug: glyceryl trinitrate
    drug_mesh: MESH:D005996
    drugbank: DB:DB00727
  links:
    - key: produces
      source: MESH:D005996
      target: CHEBI:16480
    - key: positively regulates
      source: CHEBI:16480
      target: MESH:D000071756
    - key: positively regulates
      source: MESH:D000071756
      target: GO:0019934
    - key: positively regulates
      source: MESH:D000071756
      target: GO:0019934
    - key: positively correlated with
      source: GO:0019934
      target: GO:0042311
    - key: positively regulates
      source: CHEBI:16480
      target: UniProt:P16066
    - key: positively regulates
      source: UniProt:P16066
      target: GO:0019934
    - key: negatively correlated with
      source: GO:0042311
      target: MESH:D000787
  multigraph: true
  nodes:
    - id: MESH:D005996
      label: Drug
      name: glyceryl trinitrate
      alt_names:
         - Nitroglycerin
    - id: CHEBI:16480
      label: ChemicalSubstance
      name: nitric oxide
    - id: UniProt:P16066
      label: Protein
      name: Atrial natriuretic peptide receptor 1
    - id: MESH:D000071756
      label: Protein
      name: Soluble Guanylyl Cyclase
    - id: GO:0019934
      label: BiologicalProcess
      name: cGMP-mediated signaling
    - id: GO:0042311
      label: BiologicalProcess
      name: vasodilation
    - id: MESH:D000787
      label: Disease
      name: Angina pectoris
  reference: https://go.drugbank.com/drugs/DB00727#mechanism-of-action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL730/ https://en.wikipedia.org/wiki/Nitroglycerin#Medical_use
  comments: The activation of Atrial natriuretic peptide receptor 1 has been observed in vitro (https://pubmed.ncbi.nlm.nih.gov/12890708/) and it's reported in DrugBank whereas ChEMBL favours the Soluble Guanylyl Cyclase route. Also note that when the drug is admnistered at low doses, it dilates veins and reduces the volume of blood in the heart after filling (this is supposedly the main mechanism of action). At higher doses, it dilates arteries as well.
- directed: true
  graph:
    disease: T-cell acute lymphoblastic leukemia
    disease_mesh: MESH:D054218
    drug: nelarabine
    drug_mesh: MESH:C104457
    drugbank: DB:DB01280
  links:
    - key: produces
      source: MESH:C104457
      target: MESH:C022206
    - key: decreases activity of
      source: MESH:C022206
      target: UniProt:P09884
    - key: positively regulates
      source: UniProt:P09884
      target: GO:0006260
    - key: positively correlated with
      source: GO:0006260
      target: HP:0031379
    - key: prevents
      source: MESH:C022206
      target: GO:0090592
    - key: positively correlated with
      source: GO:0090592
      target: HP:0031379
    - key: positively correlated with
      source: HP:0031379
      target: MESH:D054218
  multigraph: true
  nodes:
    - id: MESH:C104457
      label: Drug
      name: nelarabine
    - id: MESH:C022206
      label: ChemicalSubstance
      name: 9-beta-D-arabinofuranosylguanosine 5'-triphosphate
    - id: UniProt:P09884
      label: Protein
      name: DNA polymerase alpha catalytic subunit
    - id: GO:0090592
      label: BiologicalProcess
      name: DNA synthesis involved in DNA replication
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031379
      label: PhenotypicFeature
      name: Abnormal T cell proliferation
    - id: MESH:D054218
      label: Disease
      name: T-cell acute lymphoblastic leukemia
  reference: https://go.drugbank.com/drugs/DB01280#mechanism-of-action https://en.wikipedia.org/wiki/Nelarabine
- directed: true
  graph:
    disease: Niacin deficiency
    disease_mesh: MESH:D010383
    drug: nicotine
    drug_mesh: MESH:D009538
    drugbank: DB:DB00184
  links:
    - key: treats
      source: MESH:D009538
      target: MESH:D010383
  multigraph: true
  nodes:
    - id: MESH:D009538
      label: Drug
      name: nicotine
      alt_ids:
         - MESH:D061485
    - id: MESH:D010383
      label: Disease
      name: Niacin deficiency
  reference: https://go.drugbank.com/drugs/DB00184#indication https://en.wikipedia.org/wiki/Nicotine#Biosynthesis https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3/ https://hopes.stanford.edu/nicotinamide/#relationship-between-nicotinamide-and-nicotine
  comments: There appears to be no connection between Niacin deficiency and nicotine. Although niacin and nicotine are somehow related (nicotine can turn into nicotinic acid via oxidation), nicotine may not be able to replace niacin as treatment for Niacin deficiency. Actually nicotine could compete with niacin for binding sites in the enzymes necessary for vitamin B3 metabolism, and therefore would decrease the amount of B3 available for the cells.
- directed: true
  graph:
    disease: Hereditary angioneurotic edema
    disease_mesh: MESH:D054179
    drug: stanozolol
    drug_mesh: MESH:D013197
    drugbank: DB:DB06718
  links:
    - key: positively regulates
      source: MESH:D013197
      target: UniProt:P05155
    - key: negatively regulates
      source: UniProt:P05155
      target: GO:0006956
    - key: positively correlated with
      source: GO:0006956
      target: MESH:D001920
    - key: negatively correlated with
      source: UniProt:P05155
      target: MESH:D007610
    - key: positively correlated with
      source: MESH:D007610
      target: MESH:D001920
    - key: positively correlated with
      source: MESH:D001920
      target: MESH:D002199
    - key: positively correlated with
      source: MESH:D001920
      target: GO:0042311
    - key: positively correlated with
      source: MESH:D002199
      target: MESH:D054179
    - key: positively correlated with
      source: GO:0042311
      target: MESH:D054179
  multigraph: true
  nodes:
    - id: MESH:D013197
      label: Drug
      name: stanozolol
    - id: UniProt:P05155
      label: Protein
      name: Plasma protease C1 inhibitor
    - id: GO:0006956
      label: BiologicalProcess
      name: complement activation
    - id: GO:0042311
      label: BiologicalProcess
      name: vasodilation
    - id: MESH:D007610
      label: Protein
      name: Kallikreins
    - id: MESH:D001920
      label: Protein
      name: Bradykinin
    - id: MESH:D002199
      label: BiologicalProcess
      name: Capillary Permeability
    - id: MESH:D054179
      label: Disease
      name: Hereditary angioneurotic edema
  reference: https://en.wikipedia.org/wiki/C1-inhibitor https://en.wikipedia.org/wiki/Bradykinin https://en.wikipedia.org/wiki/Kallikrein https://en.wikipedia.org/wiki/Kinin%E2%80%93kallikrein_system#C1-INH_Involvement https://en.wikipedia.org/wiki/Hereditary_angioedema https://en.wikipedia.org/wiki/Complement_system#Regulation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666183/
  comments: Both DrugBank (https://go.drugbank.com/drugs/DB06718#mechanism-of-action) and ChEMBL (https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2079587/) have this drug modulating target AR (UniProt:P10275) but that's not the mechanism of action for this disease (MESH:D054179).
- directed: true
  graph:
    disease: Obstructive hyperbilirubinemia
    disease_mesh: MESH:D041781
    drug: menadiol sodium diphosphate
    drug_mesh: null
    drugbank: DB:DB06718
  links:
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P00734
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P08709
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P00740
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P00742
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P04070
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P38435
    - key: positively regulates
      source: DB:DB06718
      target: UniProt:P07225
    - key: regulates
      source: UniProt:P07225
      target: GO:0007596
    - key: positively regulates
      source: UniProt:P38435
      target: GO:0007596
    - key: regulates
      source: UniProt:P04070
      target: GO:0007596
    - key: positively regulates
      source: UniProt:P00742
      target: GO:0007596
    - key: positively regulates
      source: UniProt:P00740
      target: GO:0007596
    - key: positively regulates
      source: UniProt:P08709
      target: GO:0007596
    - key: positively regulates
      source: UniProt:P00734
      target: GO:0007596
    - key: prevents
      source: GO:0007596
      target: HP:0011029
    - key: manifestation of
      source: HP:0011029
      target: MESH:D041781
  multigraph: true
  nodes:
    - id: DB:DB06718
      label: Drug
      name: menadiol sodium diphosphate
    - id: UniProt:P00734
      label: Protein
      name: Prothrombin
    - id: UniProt:P08709
      label: Protein
      name: Coagulation factor VII
    - id: UniProt:P00740
      label: Protein
      name: Coagulation factor IX
    - id: UniProt:P00742
      label: Protein
      name: Coagulation factor X
    - id: UniProt:P04070
      label: Protein
      name: Vitamin K-dependent protein C
    - id: UniProt:P38435
      label: Protein
      name: Vitamin K-dependent gamma-carboxylase
    - id: UniProt:P07225
      label: Protein
      name: Vitamin K-dependent protein S
    - id: GO:0007596
      label: BiologicalProcess
      name: blood coagulation
    - id: HP:0011029
      label: PhenotypicFeature
      name: Internal hemorrhage
    - id: MESH:D041781
      label: Disease
      name: Obstructive hyperbilirubinemia
  reference: https://journals.sagepub.com/doi/abs/10.3181/00379727-37-9668P https://www.medicalnewstoday.com/articles/165749#complications https://en.wikipedia.org/wiki/Vitamin_K#History
  comments: If the bile duct (or biliary tract) is obstructed and it leads to jaundice, uncontrolled bleeding may result. In this case, vitamin K would prevent complications due to hemorrhage. Vitamin K allows for prothrombin to bind calcium, as part of a blood clotting process to stop life-threatening hemorrhage. Note that marketing for this drug has been discontinued and is not available in North America due to its likely carcinogenic potential and cytotoxic properties.
- directed: true
  graph:
    disease: Hemorrhage
    disease_mesh: MESH:D006470
    drug: menadiol sodium diphosphate
    drug_mesh: null
    drugbank: DB:DB06718
  links:
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P00734
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P08709
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P00740
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P00742
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P04070
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P38435
  - key: positively regulates
    source: DB:DB06718
    target: UniProt:P07225
  - key: regulates
    source: UniProt:P07225
    target: GO:0007596
  - key: positively regulates
    source: UniProt:P38435
    target: GO:0007596
  - key: regulates
    source: UniProt:P04070
    target: GO:0007596
  - key: positively regulates
    source: UniProt:P00742
    target: GO:0007596
  - key: positively regulates
    source: UniProt:P00740
    target: GO:0007596
  - key: positively regulates
    source: UniProt:P08709
    target: GO:0007596
  - key: positively regulates
    source: UniProt:P00734
    target: GO:0007596
  - key: negatively correlated with
    source: GO:0007596
    target: MESH:D006470
  multigraph: true
  nodes:
  - id: DB:DB06718
    label: Drug
    name: menadiol sodium diphosphate
  - id: UniProt:P00734
    label: Protein
    name: Prothrombin
  - id: UniProt:P08709
    label: Protein
    name: Coagulation factor VII
  - id: UniProt:P00740
    label: Protein
    name: Coagulation factor IX
  - id: UniProt:P00742
    label: Protein
    name: Coagulation factor X
  - id: UniProt:P04070
    label: Protein
    name: Vitamin K-dependent protein C
  - id: UniProt:P38435
    label: Protein
    name: Vitamin K-dependent gamma-carboxylase
  - id: UniProt:P07225
    label: Protein
    name: Vitamin K-dependent protein S
  - id: GO:0007596
    label: BiologicalProcess
    name: blood coagulation
  - id: MESH:D006470
    label: Disease
    name: Hemorrhage
  reference: https://journals.sagepub.com/doi/abs/10.3181/00379727-37-9668P https://www.medicalnewstoday.com/articles/165749#complications https://en.wikipedia.org/wiki/Vitamin_K#History
  comments: Marketing for this drug has been discontinued and is not available in North America due to its likely carcinogenic potential and cytotoxic properties.
- directed: true
  graph:
    disease: Pheochromocytoma
    disease_mesh: MESH:D010673
    drug: phenoxybenzamine
    drug_mesh: MESH:D010643
    drugbank: DB:DB06718
  links:
  - key: decreases activity of
    source: MESH:D010643
    target: MESH:D011942
  - key: positively regulates
    source: MESH:D011942
    target: GO:0042310
  - key: positively correlated with
    source: GO:0042310
    target: MESH:D014655
  - key: positively correlated with
    source: MESH:D014655
    target: HP:0002640
  - key: manifestation of
    source: HP:0002640
    target: MESH:D010673
  multigraph: true
  nodes:
  - id: MESH:D010643
    label: Drug
    name: phenoxybenzamine
  - id: MESH:D011942
    label: GeneFamily
    name: Receptors, Adrenergic, alpha
  - id: GO:0042310
    label: BiologicalProcess
    name: vasoconstriction
  - id: MESH:D014655
    label: BiologicalProcess
    name: Vascular Resistance
  - id: HP:0002640
    label: PhenotypicFeature
    name: Hypertension associated with pheochromocytoma
  - id: MESH:D010673
    label: Disease
    name: Pheochromocytoma
  reference: https://go.drugbank.com/drugs/DB00925#mechanism-of-action https://en.wikipedia.org/wiki/Alpha_blocker#Hypertension https://en.wikipedia.org/wiki/Phenoxybenzamine#Pharmacology https://en.wikipedia.org/wiki/Pheochromocytoma#Alpha_blockade
  comments: Phenoxybenzamine is an alpha blocker (https://en.wikipedia.org/wiki/Alpha_blocker#Pheochromocytoma https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL753/).
- directed: true
  graph:
    disease: Nicotine dependence
    disease_mesh: MESH:D014029
    drug: nicotine
    drug_mesh: MESH:D009538
    drugbank: DB:DB00184
  links:
  - key: increases activity of
    source: MESH:D009538
    target: MESH:D011950
  - key: participates in
    source: MESH:D011950
    target: REACT:R-HSA-629587﻿
  - key: participates in
    source: MESH:D011950
    target: REACT:R-HSA-629594﻿
  - key: positively correlated with
    source: REACT:R-HSA-629587﻿
    target: GO:0051899
  - key: positively correlated with
    source: REACT:R-HSA-629594﻿
    target: GO:0051899
  - key: positively correlated with
    source: GO:0051899
    target: GO:0014046
  - key: positively correlated with
    source: GO:0014046
    target: HP:0030858
  - key: positively correlated with
    source: HP:0030858
    target: MESH:D014029
  multigraph: true
  nodes:
  - id: MESH:D009538
    label: Drug
    name: nicotine
    alt_ids:
      - MESH:D061485
  - id: MESH:D011950
    label: GeneFamily
    name: Receptors, Cholinergic
  - id: REACT:R-HSA-629587﻿
    label: Pathway
    name: Highly sodium permeable postsynaptic acetylcholine nicotinic receptors
  - id: REACT:R-HSA-629594﻿
    label: Pathway
    name: Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
  - id: GO:0051899
    label: BiologicalProcess
    name: membrane depolarization
  - id: GO:0014046
    label: BiologicalProcess
    name: dopamine secretion
  - id: HP:0030858
    label: PhenotypicFeature
    name: Addictive behavior
  - id: MESH:D014029
    label: Disease
    name: Nicotine dependence
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3/ https://en.wikipedia.org/wiki/Nicotine_replacement_therapy#Mechanism_of_action https://en.wikipedia.org/wiki/Nicotine_dependence#Biomolecular https://en.wikipedia.org/wiki/Nicotine#Pharmacodynamics
